Monday, December 23, 2024
HomeTagsNonagen Bioscience

Nonagen Bioscience

Nonagen Bioscience Announces CE Mark for Oncuria Bladder Cancer Diagnostic

Nonagen Bioscience, a cancer diagnostics company, announced CE marking for its Oncuria immunoassay for bladder cancer. Oncuria is the first-of-its-kind multiplex urine test for the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics